NCT03829436 2023-07-03TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersTempest TherapeuticsPhase 1 Completed38 enrolled
NCT04891718 2022-07-08CIVO Intratumoural Microdosing of Anti-Cancer Therapies in AustraliaPresage BiosciencesPhase EARLY_PHASE1 Withdrawn
NCT03056599 2021-09-24Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue SarcomaPresage BiosciencesPhase 1 Completed23 enrolled